Tag: Diffusion Pharmaceuticals


Diffusion Pharmaceuticals Inc (NASDAQ: DFFN): New Therapies to Enhance Body Ability to Deliver Oxygen

Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) is an biopharmaceutical company which keeps on working on new therapies, announced results of the company’s phase I trial of its lead product candidate, trans sodium crocetinate (“TSC”), that helps in enhancing the ability to circulate oxygen to those critical areas of the body where […]